ENDOGENOUS ANTI-OPIATE ANALGESIA SYSTEMS
内源性抗阿片类镇痛系统
基本信息
- 批准号:3418505
- 负责人:
- 金额:$ 15.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-09-29 至 1997-09-28
- 项目状态:已结题
- 来源:
- 关键词:analgesia auditory stimulus avoidance behavior cholecystokinin conditioning cues dosage drug interactions dynorphins electrostimulus enkephalins environmental stressor laboratory rat morphine narcotic antagonists neuropharmacology neurophysiology neutralizing antibody opioid receptor pain threshold photostimulus spinal cord thyrotropin releasing hormone visual stimulus
项目摘要
The CNS contains circuitry which can inhibit pain, thereby producing
analgesia. This pain inhibitory circuitry can be activated by acute
exposure of the organism to aversive/stressful environmental stimuli.
Animals can also learn cues that predict that they will be exposed to
aversive/stressful environmental stimuli, & become analgesic in response
to these cues, called danger signals. Observations such as these led to
the widely held view that the physiological function of such circuitry
is to suppress pain during threatening situations, since pain perception
at such a time would compromise efficient defense/escape behavior.
Recent evidence strongly suggests the existence of neural circuitry with
a function opposing that described above. That is this circuitry appears
to specifically block analgesia, thereby producing anti-analgesia. To
date, this blockade has been found only for opiate analgesias. Therefore
it is possible that this is a specific "anti-opiate analgesia" system.
A number of candidate anti-opiate analgesia neurotransmitters have been
identified (e.g., CCK & FMRFamide). Injection of receptor agonists of
such substances blocks opiate analgesias whereas receptor antagonists can
markedly enhance the onset, peak effect & duration of a variety of opiate
analgesic states.
In addition to being able to learn danger signals, animals can learn cues
that predict the non-occurrence of aversive events. For example, they
can learn a light cue that signals that shock will not occur for a period
of time. Thus, the light cue serves as a safety signal. It is now known
that safety signals activate anti-opiate analgesia. That is, various
opiate analgesias, including systemic & spinal morphine analgesias, are
abolished by presentation of the safety signal. It is clear from these
dramatic data that an understanding of endogenous anti-analgesia systems
that function to oppose opiate analgesia may potentially provide novel
approaches for the control of pain.
The aim of the present proposal is to investigate the endogenous
mechanisms underlying anti-analgesia. Dose-response studies will
characterize the effect of the safety signal on opiate & non-opiate drug-
& stress-induced analgesias, & will identify anti-analgesic substances
mediating these effects. Time-response studies will characterize the
development & duration of anti-analgesia. Generality of the safety
signal effects will be examined by varying the stimulus used as the
safety signal, by varying the conditioning parameters, & by varying the
pain measures. By addressing well-defined, basic questions the proposed
studies should provide major insights into the mechanisms underlying this
newly discovered neural circuitry.
中枢神经系统包含可以抑制疼痛的电路,从而产生
镇痛。 这种疼痛抑制作用可以通过急性激活
将生物体暴露于厌恶/压力的环境刺激中。
动物还可以学习提示,以预测它们会暴露于
厌恶/压力的环境刺激,并成为镇痛作用
对于这些提示,称为危险信号。 这样的观察导致
这种电路的生理功能广泛认为
是为了在威胁情况下抑制疼痛,因为疼痛感
在这样的时候,将损害有效的防御/逃脱行为。
最近的证据强烈表明存在神经回路
与上述相反的功能。 那就是这个电路出现
特异性地阻断镇痛,从而产生抗扰动。 到
日期,仅针对阿片类镇痛而发现了这种封锁。 所以
这可能是一个特定的“抗核心镇痛”系统。
许多候选抗焦虑镇痛神经递质已经
已识别(例如CCK和FMRFAMIDE)。 注射受体激动剂
这样的物质阻止了阿片类镇痛,而受体拮抗剂可以
明显增强了各种鸦片的发作,峰值效应和持续时间
镇痛状态。
除了能够学习危险信号外,动物还可以学习提示
这可以预测厌恶事件的非发生。 例如,他们
可以学习一个信号,表明一段时间内不会发生冲击
时间。 因此,光提示是安全信号。 现在已知
该安全信号激活了抗焦点镇痛。 也就是说,各种各样
阿片类镇痛,包括全身和脊髓镇痛,是
通过呈现安全信号废除。 从这些可以清楚地
理解内源性抗分析系统的戏剧性数据
反对阿片类镇痛的功能可能有可能提供新颖的
控制疼痛的方法。
本提案的目的是研究内源性
抗障碍的机制。 剂量反应研究将
表征安全信号对阿片类药物和非伴侣药物的影响
&压力引起的镇痛,并将识别抗动物物质
调解这些效果。 时间响应研究将表征
反扰流的发展和持续时间。 安全的一般性
通过改变用作的刺激来检查信号效应
安全信号,通过改变条件参数,并通过改变
疼痛措施。 通过解决定义明确的基本问题
研究应提供有关此机制的主要见解
新发现的神经回路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LINDA WATKINS其他文献
LINDA WATKINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LINDA WATKINS', 18)}}的其他基金
Enduring enhancement of neuropathic pain by early post-trauma morphine
创伤后早期吗啡持久增强神经性疼痛
- 批准号:
9906887 - 财政年份:2018
- 资助金额:
$ 15.63万 - 项目类别:
Enduring enhancement of neuropathic pain by early post-trauma morphine
创伤后早期吗啡持久增强神经性疼痛
- 批准号:
10393512 - 财政年份:2018
- 资助金额:
$ 15.63万 - 项目类别:
Targeting toll like receptor 4 (TLR4) and TLR2 to resolve EAE-associated paralysis, pain and cognitive deficits: efficacy of a clinically-relevant blood brain barrier permeable TLR4/TLR2 antagonist
靶向 Toll 样受体 4 (TLR4) 和 TLR2 以解决 EAE 相关的麻痹、疼痛和认知缺陷:临床相关血脑屏障可渗透性 TLR4/TLR2 拮抗剂的功效
- 批准号:
9153350 - 财政年份:2016
- 资助金额:
$ 15.63万 - 项目类别:
Targeting neuropathic pain prevention: Modulating the neuroimmunology of peripheral nerve injury
以预防神经病理性疼痛为目标:调节周围神经损伤的神经免疫学
- 批准号:
10062833 - 财政年份:2016
- 资助金额:
$ 15.63万 - 项目类别:
Spinal adenosine modulator: enduring anti-inflammatory action in neuropathic pain
脊髓腺苷调节剂:对神经性疼痛具有持久的抗炎作用
- 批准号:
7805660 - 财政年份:2009
- 资助金额:
$ 15.63万 - 项目类别:
Spinal adenosine modulator: enduring anti-inflammatory action in neuropathic pain
脊髓腺苷调节剂:对神经性疼痛具有持久的抗炎作用
- 批准号:
7937819 - 财政年份:2009
- 资助金额:
$ 15.63万 - 项目类别:
Models and mechanisms for the transition of acute-to-chronic orofacial pain
急性至慢性口面部疼痛转变的模型和机制
- 批准号:
7936108 - 财政年份:2009
- 资助金额:
$ 15.63万 - 项目类别:
Models and mechanisms for the transition of acute-to-chronic orofacial pain
急性至慢性口面部疼痛转变的模型和机制
- 批准号:
7805658 - 财政年份:2009
- 资助金额:
$ 15.63万 - 项目类别:
Optoid Analgesics: Modulation of Trigeminal & Spinal Glial Activation
Optoid 镇痛药:三叉神经的调节
- 批准号:
7840785 - 财政年份:2009
- 资助金额:
$ 15.63万 - 项目类别:
Exploring the Potential of Glia for Regulating Clinically Relevant Opiod Actions
探索神经胶质细胞调节临床相关阿片类药物作用的潜力
- 批准号:
8267435 - 财政年份:2008
- 资助金额:
$ 15.63万 - 项目类别:
相似国自然基金
TMS同步刺激颞上回和前运动皮层促进听觉-运动整合改善帕金森病言语障碍的神经机制
- 批准号:82302859
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
听觉刺激特异性调控情绪的神经环路机制研究
- 批准号:82371516
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
术前经颅磁刺激联合术后言语训练在语前聋患者人工耳蜗植入后听觉言语康复的作用及中枢机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
术前经颅磁刺激联合术后言语训练在语前聋患者人工耳蜗植入后听觉言语康复的作用及中枢机制研究
- 批准号:82201279
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
听觉-体感联合刺激下的大脑响应强化诱导机制及微意识检测方法
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:
相似海外基金
Basal ganglia circuit mechanisms for threat coping
应对威胁的基底神经节回路机制
- 批准号:
10727893 - 财政年份:2023
- 资助金额:
$ 15.63万 - 项目类别:
Predicting maladaptive aversive learning via computational modeling of insular single cell ensemble activity patterns
通过岛叶单细胞整体活动模式的计算模型来预测适应不良的厌恶学习
- 批准号:
10575313 - 财政年份:2023
- 资助金额:
$ 15.63万 - 项目类别:
Photopharmacological interrogation of presynaptic neuromodulation of cortico-amygdalar circuits
皮质杏仁核回路突触前神经调节的光药理学研究
- 批准号:
10666359 - 财政年份:2022
- 资助金额:
$ 15.63万 - 项目类别:
A novel role for higher order auditory circuits: social group dynamics and descending pathways to the Social Behavior Network
高阶听觉回路的新作用:社会群体动态和社会行为网络的下降路径
- 批准号:
10671537 - 财政年份:2022
- 资助金额:
$ 15.63万 - 项目类别:
A novel role for higher order auditory circuits: social group dynamics and descending pathways to the Social Behavior Network
高阶听觉回路的新作用:社会群体动态和社会行为网络的下降路径
- 批准号:
10507454 - 财政年份:2022
- 资助金额:
$ 15.63万 - 项目类别: